Impact of fluid status and inflammation and their interaction on survival

Autor: Yuedong Wang, Paola Carioni, Aileen Grassmann, Vaibhav Maheshwari, Frank M. van der Sande, Bernard Canaud, Xiaoling Ye, Len A. Usvyat, Constantijn J.A.M. Konings, Peter Kotanko, Marijke J E Dekker, Karel M.L. Leunissen, Jeroen P. Kooman, Nathan W. Levin, Daniele Marcelli
Přispěvatelé: MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), MUMC+: MA Nefrologie (9), RS: CARIM - R3.02 - Hypertension and target organ damage, Interne Geneeskunde, RS: NUTRIM - R3 - Respiratory & Age-related Health, RS: NUTRIM - R3 - Chronic inflammatory disease and wasting
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
CHRONIC KIDNEY-DISEASE
medicine.medical_specialty
NUTRITIONAL-STATUS
medicine.medical_treatment
030232 urology & nephrology
Water-Electrolyte Imbalance
Inflammation
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
fluid status
Renal Dialysis
Risk Factors
Internal medicine
Extracellular fluid
medicine
Electric Impedance
Humans
PERITONEAL-DIALYSIS PATIENTS
Significant risk
Aged
Proportional Hazards Models
body composition
hemodialysis
business.industry
MORTALITY
Hazard ratio
OVERLOAD
Middle Aged
Confidence interval
C-REACTIVE PROTEIN
Surgery
Body Fluids
Nephrology
inflammation
Cohort
VOLUME
Cardiology
Kidney Failure
Chronic

Female
Hemodialysis
WEIGHT
medicine.symptom
CARDIAC BIOMARKERS
business
Cohort study
Follow-Up Studies
BIOIMPEDANCE SPECTROSCOPY
Zdroj: Kidney International, 91(5), 1214-1223. Elsevier Science
ISSN: 0085-2538
Popis: In hemodialysis patients extracellular fluid overload is a predictor of all-cause and cardiovascular mortality, and a relation with inflammation has been reported in previous studies. The magnitude and nature of this interaction and the effects of moderate fluid overload and extracellular fluid depletion on survival are still unclear. We present the results of an international cohort study in 8883 hemodialysis patients from the European MONDO initiative database where, during a three-month baseline period, fluid status was assessed using bioimpedance and inflammation by C-reactive protein. All-cause mortality was recorded during 12 months of follow up. In a second analysis a three-month baseline period was added to the first baseline period, and changes in fluid and inflammation status were related to all-cause mortality during six-month follow up. Both pre-dialysis estimated fluid overload and fluid depletion were associated with an increased mortality, already apparent at moderate levels of estimated pre dialysis fluid overload (1.1-2.5L); hazard ratio 1.64 (95% confidence interval 1.35-1.98). In contrast, post-dialysis estimated fluid depletion was associated with a survival benefit (0.74 [0.62-0.90]). The concurrent presence of fluid overload and inflammation was associated with the highest risk of death. Thus, while pre-dialysis fluid overload was associated with inflammation, even in the absence of inflammation, fluid overload remained a significant risk factor for short-term mortality, even following improvement of fluid status.
Databáze: OpenAIRE